Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus 16”

249 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 249 results

Large-scale testing (Phase 3)Study completedNCT05372016
What this trial is testing

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Testing effectiveness (Phase 2)Ended earlyNCT03610581
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Who this might be right for
Human Papillomavirus Infections
Janssen Vaccines & Prevention B.V. 9
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Early research (Phase 1)Study completedNCT04084951
What this trial is testing

Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 30
Not applicableUnknownNCT00154583
What this trial is testing

Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions

Who this might be right for
Cervical Cancer
National Taiwan University Hospital 500
Large-scale testing (Phase 3)UnknownNCT05580341
What this trial is testing

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Who this might be right for
Cervical CancerGenital WartCIN+2 more
Shanghai Zerun Biotechnology Co.,Ltd 1,200
Not applicableStudy completedNCT02551887
What this trial is testing

HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 647
Large-scale testing (Phase 3)Study completedNCT01304498
What this trial is testing

Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)

Who this might be right for
Human Papillomavirus
Merck Sharp & Dohme LLC 600
Testing effectiveness (Phase 2)Study completedNCT03499795
What this trial is testing

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Who this might be right for
Anal Neoplasm
Inovio Pharmaceuticals 23
Large-scale testing (Phase 3)Study completedNCT02733068
What this trial is testing

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical Intraepithelial Neoplasia
Shanghai Zerun Biotechnology Co.,Ltd 12,000
Not applicableStudy completedNCT03671369
What this trial is testing

A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Who this might be right for
Neoplasms, Rectal
GlaxoSmithKline 670
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Large-scale testing (Phase 3)Study completedNCT00169494
What this trial is testing

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 770
Testing effectiveness (Phase 2)Study completedNCT05694728
What this trial is testing

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, Inc 780
Not applicableUnknownNCT01427777
What this trial is testing

3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China

Who this might be right for
Anogenital Human Papilloma Virus Infection
Guangxi Center for Disease Control and Prevention 300
Testing effectiveness (Phase 2)Looking for participantsNCT05280457
What this trial is testing

HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yonsei University 21
Testing effectiveness (Phase 2)Study completedNCT02280811
What this trial is testing

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Who this might be right for
Vaginal CancerCervical CancerAnal Cancer+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT06319963
What this trial is testing

Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Who this might be right for
HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Theravectys S.A. 72
Testing effectiveness (Phase 2)Study completedNCT01304524
What this trial is testing

VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Who this might be right for
Cervical Intraepithelial Neoplasia
Inovio Pharmaceuticals 167
Load More Results